First, there often are critical differences in clinical safety or effectiveness among drugs that act through similar mechanisms. Second, even if two drugs are each effective in 40% of patients with a particular symptom or disease, each of them may not work in the same 40%. Third, “supplemental,” or secondary, approvals of drugs — which […]
via John Goodman's Health Policy Blog http://healthblog.ncpa.org/a-medicine-that-differs-slightly-from-another-can-have-a-big-health-benefit/
via John Goodman's Health Policy Blog http://healthblog.ncpa.org/a-medicine-that-differs-slightly-from-another-can-have-a-big-health-benefit/
No comments:
Post a Comment